GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $478,000 | -83.7% | 11,005 | -83.6% | 0.00% | -75.0% |
| Q1 2022 | $2,940,000 | +18.3% | 67,214 | +19.5% | 0.00% | +100.0% |
| Q4 2021 | $2,486,000 | -41.6% | 56,265 | -49.5% | 0.00% | -50.0% |
| Q3 2021 | $4,260,000 | +54.0% | 111,394 | +60.5% | 0.00% | +33.3% |
| Q2 2021 | $2,766,000 | +453.2% | 69,413 | +396.1% | 0.00% | +200.0% |
| Q1 2021 | $500,000 | -41.9% | 13,991 | -40.2% | 0.00% | 0.0% |
| Q4 2020 | $861,000 | -31.8% | 23,407 | -30.3% | 0.00% | -50.0% |
| Q3 2020 | $1,263,000 | -28.2% | 33,578 | -22.1% | 0.00% | -33.3% |
| Q2 2020 | $1,758,000 | -27.4% | 43,110 | -32.7% | 0.00% | -50.0% |
| Q1 2020 | $2,422,000 | +11.3% | 64,098 | +39.3% | 0.01% | +50.0% |
| Q4 2019 | $2,176,000 | -22.5% | 45,998 | -30.1% | 0.00% | -20.0% |
| Q3 2019 | $2,807,000 | -63.7% | 65,769 | -65.9% | 0.01% | -66.7% |
| Q2 2019 | $7,725,000 | -65.6% | 193,053 | -64.1% | 0.02% | -63.4% |
| Q1 2019 | $22,487,000 | +216.7% | 538,068 | +190.2% | 0.04% | +215.4% |
| Q4 2018 | $7,100,000 | +112.8% | 185,417 | +123.2% | 0.01% | +160.0% |
| Q3 2018 | $3,336,000 | +48.0% | 83,071 | +48.5% | 0.01% | +25.0% |
| Q2 2018 | $2,254,000 | -67.5% | 55,929 | -68.5% | 0.00% | -60.0% |
| Q1 2018 | $6,932,000 | +158.3% | 177,433 | +134.5% | 0.01% | +150.0% |
| Q4 2017 | $2,684,000 | +25.7% | 75,678 | +43.9% | 0.00% | +33.3% |
| Q3 2017 | $2,135,000 | +14.4% | 52,598 | +21.6% | 0.00% | 0.0% |
| Q2 2017 | $1,866,000 | +22.8% | 43,256 | +20.0% | 0.00% | 0.0% |
| Q1 2017 | $1,520,000 | -15.3% | 36,044 | -22.6% | 0.00% | -25.0% |
| Q4 2016 | $1,795,000 | -21.4% | 46,568 | -12.2% | 0.00% | -33.3% |
| Q3 2016 | $2,285,000 | -4.5% | 53,029 | -3.9% | 0.01% | -14.3% |
| Q2 2016 | $2,393,000 | +8.4% | 55,181 | +1.4% | 0.01% | +16.7% |
| Q1 2016 | $2,208,000 | +21.1% | 54,422 | +20.8% | 0.01% | +50.0% |
| Q4 2015 | $1,823,000 | -76.8% | 45,056 | -77.9% | 0.00% | -80.0% |
| Q3 2015 | $7,853,000 | +473.2% | 204,203 | +520.8% | 0.02% | +900.0% |
| Q2 2015 | $1,370,000 | +217.1% | 32,895 | +251.0% | 0.00% | +100.0% |
| Q1 2015 | $432,000 | -24.5% | 9,371 | -30.0% | 0.00% | 0.0% |
| Q4 2014 | $572,000 | +41.6% | 13,390 | +52.6% | 0.00% | 0.0% |
| Q3 2014 | $404,000 | +102.0% | 8,777 | +134.3% | 0.00% | – |
| Q2 2014 | $200,000 | -11.9% | 3,746 | -11.9% | 0.00% | -100.0% |
| Q1 2014 | $227,000 | -47.5% | 4,253 | -47.4% | 0.00% | 0.0% |
| Q4 2013 | $432,000 | +4.1% | 8,087 | -2.4% | 0.00% | 0.0% |
| Q3 2013 | $415,000 | +5.9% | 8,284 | +5.4% | 0.00% | 0.0% |
| Q2 2013 | $392,000 | -8.6% | 7,863 | -14.1% | 0.00% | -50.0% |
| Q1 2013 | $429,000 | -1.4% | 9,151 | -8.4% | 0.00% | 0.0% |
| Q4 2012 | $435,000 | -8.8% | 9,988 | -3.1% | 0.00% | 0.0% |
| Q3 2012 | $477,000 | -18.7% | 10,309 | -20.0% | 0.00% | -33.3% |
| Q2 2012 | $587,000 | -8.1% | 12,892 | -9.4% | 0.00% | 0.0% |
| Q1 2012 | $639,000 | – | 14,230 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 6,324,319 | $241,621,000 | 32.36% |
| Black Creek Investment Management Inc. | 10,329,349 | $394,684,000 | 11.46% |
| Healthcare Value Capital, LLC | 100,000 | $3,821,000 | 7.54% |
| KAHN BROTHERS GROUP INC | 1,353,358 | $51,711,809,000 | 7.28% |
| EQUITY INVESTMENT CORP | 2,924,326 | $111,738,000 | 4.28% |
| Eversept Partners, LP | 1,503,700 | $57,456,377 | 3.99% |
| NKCFO LLC | 269,500 | $10,298,000 | 3.45% |
| Robinson Value Management, Ltd. | 96,990 | $3,706,000 | 3.31% |
| Keystone Financial Planning, Inc. | 237,691 | $9,082,000 | 3.30% |
| CLIFFORD CAPITAL PARTNERS LLC | 93,485 | $3,572,000 | 3.27% |